Cover Image
市場調查報告書

全球腫瘤切除市場 (射頻消融術·微波切除·冷凍切除·高能聚焦超音波療法、雷射消熔法):產業分析,規模,佔有率,成長率,趨勢,預測 2014-2024年

Tumor Ablation Market (Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, and Laser Interstitial Thermal Ablation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024

出版商 Transparency Market Research 商品編碼 487767
出版日期 內容資訊 英文 165 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球腫瘤切除市場 (射頻消融術·微波切除·冷凍切除·高能聚焦超音波療法、雷射消熔法):產業分析,規模,佔有率,成長率,趨勢,預測 2014-2024年 Tumor Ablation Market (Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, and Laser Interstitial Thermal Ablation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024
出版日期: 2017年03月22日 內容資訊: 英文 165 Pages
簡介

本報告提供全球腫瘤切除市場相關調查分析,提供您產業分析,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等系統系資訊。

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理

第4章 全球腫瘤切除產品市場概要

  • 簡介 (產品定義)
  • 產業的演進/發展
  • 主要市場指標
  • 市場動態
  • 全球腫瘤切除市場分析·預測
  • 腫瘤切除市場:全球供需情形
  • 波特的五力分析
  • 價值鏈分析
  • 市場展望

第5章 全球腫瘤切除市場分析·預測:各技術

  • 主要調查結果
  • 簡介
  • 市場規模預測:各技術
    • 射頻消融術
    • 微波切除
    • 冷凍切除
    • 高能聚焦超音波療法
    • 雷射消熔法
    • 其他
  • 市場魅力:各技術
  • 主要趨勢

第6章 全球腫瘤切除市場分析·預測:疾病·不同症狀

  • 主要調查結果
  • 簡介
  • 市場規模預測:疾病·不同症狀
    • 肝癌
    • 肺癌
    • 腎臟癌
    • 骨癌
    • 乳癌
    • 前列腺癌
  • 市場魅力:疾病·不同症狀
  • 主要趨勢

第7章 全球腫瘤切除市場分析·預測:各終端用戶

  • 主要調查結果
  • 簡介
  • 市場規模預測:各終端用戶
    • 家庭用戶
    • 診療所
    • 醫院
  • 市場魅力:各終端用戶
  • 主要趨勢

第8章 全球腫瘤切除市場分析·預測:各地區

  • 主要調查結果
  • 簡介
    • 市場規模預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第9章 北美的腫瘤切除市場分析·預測:各地區

  • 主要調查結果
  • 各技術
  • 疾病·不同症狀
  • 各終端用戶
  • 各國
  • 市場魅力分析
  • 市場趨勢

第10章 歐洲的腫瘤切除市場分析·預測:各地區

第11章 亞太地區的腫瘤切除市場分析·預測:各地區

第12章 南美的腫瘤切除市場分析·預測:各地區

第13章 中東·非洲 (MEA)的腫瘤切除市場分析·預測:各地區

第14章 競爭情形

  • 市場佔有率分析:各企業
  • 競爭矩陣
  • 企業簡介

圖表清單

目錄

Title:
Tumor Ablation Market
(Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, and Laser Interstitial Thermal Ablation; Disease Indication - Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, and Prostate Cancer; End Users - Hospitals and Cancer Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024.

Global Tumor Ablation Market: Overview

Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For tumor ablation procedure Ultrasound (US) or Magnetic Resonance Imaging (MRI), Computed Tomography (CT), is used to guide and position the needle probe into the tumor. A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the tumor ablation market, has been provided in this report. Market revenue for all the above mentioned segments, and their sub segments has been provided for the forecast period of 2016-2024, considering 2015 as the base year, and 2014 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2016-2024. Market share estimations were based on in-depth analysis and study of products, and their features, prices etc.

This report provides in-depth analysis of the tumor ablation market. The stakeholders for this report include companies involved in the manufacturing of ablation devices and its spares parts. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different regions. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the tumor ablation market. Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of Key Opinion Leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.

Global Tumor Ablation Market: Segmentation

Based on technology, global tumor ablation market is segmented on the basis of technology are radiofrequency ablation, microwave ablation, Cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others. Based on disease indication, the tumor ablation market are segmented into liver cancer, lung cancer, kidney cancer, bone cancer, breast cancer, prostate cancer, and others. End users in the tumor ablation market are, hospitals, cancer specialty clinics, and others (long term care center, research, academics, nursing facility, etc.)

Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Spain, Italy, Russia, rest of Europe, India, China, Japan, Australia and New Zealand, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC countries, South Africa and Rest of Middle East and Africa.

Companies Mentioned in the Report

The report also comprises list major players in the market, their SWOT analysis, market share of these players in the tumor ablation, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Medtronic plc, Integra LifeSciences Holdings Corporation, BTG International Ltd, Boston Scientific Corporation, AngioDynamics, Inc., SonaCare Medical, LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A.

The global tumor ablation market has been segmented as follows:

By Technology

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • High-Intensity Focused Ultrasound
  • Laser Interstitial Thermal Ablation
  • Others

By Material

  • Liver cancer
  • Lung cancer
  • Kidney cancer
  • Bone cancer
  • Breast cancer
  • Prostate cancer
  • Others

By End Users

  • Hospitals
  • Cancer Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC countries
    • South Africa
    • Rest of MEA

Table of Contents

1. Preface

2. Research Methodology & Assumptions

3. Executive Summary

4. Global Tumor Ablation Products Market Overview

  • 4.1. Introduction (Product Definition)
  • 4.2. Industry Evolution/Development
  • 4.3. Key Market Indicators
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunity
  • 4.5. Global Tumor Ablation Market Analysis and Forecasts, 2014-2024
  • 4.6. Tumor Ablation Market-Global Supply Demand Scenario
  • 4.7. Porter's Five Force Analysis
  • 4.8. Value Chain Analysis
  • 4.9. Market Outlook

5. Global Tumor Ablation Market Analysis and Forecast by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
  • 5.3. Market Size (US$ Mn) Forecast, By Technology
    • 5.3.1. Radiofrequency Ablation
    • 5.3.2. Microwave Ablation
    • 5.3.3. Cryoablation
    • 5.3.4. High-Intensity Focused Ultrasound
    • 5.3.5. Laser Interstitial Thermal Ablation
    • 5.3.6. Others
  • 5.4. Market Attractiveness, By Technology
  • 5.5. Key Trends

6. Global Tumor Ablation Market Analysis and Forecast by Disease Indication

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Market Size (US$ Mn) Forecast, By Disease Indication
    • 6.3.1. Liver cancer
    • 6.3.2. Lung cancer
    • 6.3.3. Kidney cancer
    • 6.3.4. Bone cancer
    • 6.3.5. Breast cancer
    • 6.3.6. Prostate cancer
    • 6.3.7. Others
  • 6.4. Market Attractiveness, By Disease Indication
  • 6.5. Key Trends

7. Global Tumor Ablation Market Analysis and Forecast by End User

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Market Size (US$ Mn) Forecast, By End User
    • 7.3.1. Home Users
    • 7.3.2. Clinics
    • 7.3.3. Hospitals
  • 7.4. Market Attractiveness, By End User
  • 7.5. Key Trends

8. Global Tumor Ablation Market Analysis and Forecast by Region

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Market Size (US$ Mn) Forecast, By Region
    • 8.2.2. North America
    • 8.2.3. Europe
    • 8.2.4. Asia Pacific
    • 8.2.5. Latin America
    • 8.2.6. Middle East and Africa

9. North America Tumor Ablation Market Analysis and Forecast by Region

  • 9.1. Key Findings
  • 9.2. North America Tumor Ablation Market Forecast, by Technology
  • 9.3. North America Tumor Ablation Market Forecast, by Disease Indication
  • 9.4. North America Tumor Ablation Market Forecast, by End User
  • 9.5. North America Tumor Ablation Market Forecast, by Country
    • 9.5.1. U.S. Tumor Ablation Market Overview
    • 9.5.2. Canada Tumor Ablation Market Overview
  • 9.6. North America Market Attractiveness Analysis
  • 9.7. Market Trends

10. Europe Tumor Ablation Market Analysis and Forecast by Region

  • 10.1. Key Findings
  • 10.2. Europe Tumor Ablation Market Forecast, by Technology
  • 10.3. Europe Tumor Ablation Market Forecast, by Disease Indication
  • 10.4. Europe Tumor Ablation Market Forecast, by End User
  • 10.5. Europe Tumor Ablation Market Forecast, by Country
    • 10.5.1. U.K. Tumor Ablation Market Overview
    • 10.5.2. Germany Tumor Ablation Market Overview
    • 10.5.3. France Tumor Ablation Market Overview
    • 10.5.4. Italy Tumor Ablation Market Overview
    • 10.5.5. Spain Tumor Ablation Market Overview
    • 10.5.6. Russia Tumor Ablation Market Overview
    • 10.5.7. Rest of Europe Tumor Ablation Market Overview
  • 10.6. Europe Market Attractiveness Analysis
  • 10.7. Market Trends

11. Asia Pacific Tumor Ablation Market Analysis and Forecast by Region

  • 11.1. Key Findings
  • 11.2. Asia Pacific Tumor Ablation Market Forecast, by Technology
  • 11.3. Asia Pacific Tumor Ablation Market Forecast, by Disease Indication
  • 11.4. Asia Pacific Tumor Ablation Market Forecast, by End User
  • 11.5. Asia Pacific Tumor Ablation Market Forecast, by Country
    • 11.5.1. India Tumor Ablation Market Overview
    • 11.5.2. China Tumor Ablation Market Overview
    • 11.5.3. Japan Tumor Ablation Market Overview
    • 11.5.4. Australia of Asia Pacific Tumor Ablation Market Overview
    • 11.5.5. Rest of APAC Tumor Ablation Market Overview
  • 11.6. Asia Pacific Market Attractiveness Analysis
  • 11.7. Market Trends

12. Latin America Tumor Ablation Market Analysis and Forecast by Region

  • 12.1. Key Findings
  • 12.2. Latin America Tumor Ablation Market Forecast, by Technology
  • 12.3. Latin America Tumor Ablation Market Forecast, by Disease Indication
  • 12.4. Latin America Tumor Ablation Market Forecast, by End User
  • 12.5. Latin America Tumor Ablation Market Forecast, by Country
    • 12.5.1. Brazil Tumor Ablation Market Overview
    • 12.5.2. Mexico Tumor Ablation Market Overview
    • 12.5.3. Rest of LATAM Tumor Ablation Market Overview
  • 12.6. Latin America Market Attractiveness Analysis
  • 12.7. Market Trends

13. Middle East and Africa Tumor Ablation Market Analysis and Forecast by Region

  • 13.1. Key Findings
  • 13.2. Middle East and Africa Tumor Ablation Market Forecast, by Technology
  • 13.3. Middle East and Africa Tumor Ablation Market Forecast, by Disease Indication
  • 13.4. Middle East and Africa Tumor Ablation Market Forecast, by End User
  • 13.5. Middle East and Africa Tumor Ablation Market Forecast, by Country
    • 13.5.1. South Africa Tumor Ablation Market Overview
    • 13.5.2. GCC countries Tumor Ablation Market Overview
    • 13.5.3. Rest of MEA Tumor Ablation Market Overview
  • 13.6. Middle East and Africa Market Attractiveness Analysis
  • 13.7. Market Trends

14. Competitive Landscape

  • 14.1. Market Share Analysis, by Company
  • 14.2. Competition Matrix
  • 14.3. Company Profiles
    • 14.3.1. Medtronic plc.
      • 14.3.1.1. Company Details
      • 14.3.1.2. Business Overview
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. Strategic Overview
      • 14.3.1.5. SWOT Analysis
    • 14.3.2. Integra LifeSciences Holdings Corporation
      • 14.3.2.1. Company Details
      • 14.3.2.2. Business Overview
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. Strategic Overview
      • 14.3.2.5. SWOT Analysis
    • 14.3.3. BTG International Ltd
      • 14.3.3.1. Company Details
      • 14.3.3.2. Business Overview
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. Strategic Overview
      • 14.3.3.5. SWOT Analysis
    • 14.3.4. Boston Scientific Corporation
      • 14.3.4.1. Company Details
      • 14.3.4.2. Business Overview
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. Strategic Overview
      • 14.3.4.5. SWOT Analysis
    • 14.3.5. AngioDynamics, Inc.
      • 14.3.5.1. Company Details
      • 14.3.5.2. Business Overview
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. Strategic Overview
      • 14.3.5.5. SWOT Analysis
    • 14.3.6. SonaCare Medical, LLC.
      • 14.3.6.1. Company Details
      • 14.3.6.2. Business Overview
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. Strategic Overview
      • 14.3.6.5. SWOT Analysis
    • 14.3.7. BVM Medical Limited
      • 14.3.7.1. Company Details
      • 14.3.7.2. Business Overview
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. Strategic Overview
      • 14.3.7.5. SWOT Analysis
    • 14.3.8. St. Jude Medical, Inc.
      • 14.3.8.1. Company Details
      • 14.3.8.2. Business Overview
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. Strategic Overview
      • 14.3.8.5. SWOT Analysis
    • 14.3.9. EDAP TMS S.A.
      • 14.3.9.1. Company Details
      • 14.3.9.2. Business Overview
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. Strategic Overview
      • 14.3.9.5. SWOT Analysis

List of Figures

  • Figure 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, 2015-2024
  • Figure 02: Global Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
  • Figure 03: Global Tumor Ablation Technology Market Revenue
  • Figure 04: Global Tumor Ablation Technology Market Revenue
  • Figure 05: Global Tumor Ablation Technology Market Revenue
  • Figure 06: Global Tumor Ablation Technology Market Revenue
  • Figure 07: Global Tumor Ablation Technology Market Revenue
  • Figure 08: Global Tumor Ablation Technology Market Revenue
  • Figure 09: Tumor Ablation Technology Market Attractiveness Analysis by Technology
  • Figure 10: Global Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
  • Figure 11: Global Tumor Ablation Disease Indication Market Revenue
  • Figure 12: Global Tumor Ablation Disease Indication Market Revenue
  • Figure 13: Global Tumor Ablation Disease Indication Market Revenue
  • Figure 14: Global Tumor Ablation Disease Indication Market Revenue
  • Figure 15: Global Tumor Ablation Disease Indication Market Revenue
  • Figure 16: Global Tumor Ablation Disease Indication Market Revenue
  • Figure 17: Global Tumor Ablation Disease Indication Market Revenue
  • Figure 18: Tumor Ablation Market Attractiveness Analysis by Disease Indication
  • Figure 19: Global Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
  • Figure 20: Global Home User Tumor Ablation Market Revenue
  • Figure 21: Global Clinics Tumor Ablation Market Revenue
  • Figure 22: Global Hospitals Tumor Ablation Market Revenue
  • Figure 23: Tumor Ablation Market Attractiveness Analysis by End User
  • Figure 24: Global Tumor Ablation Market Value Share Analysis by Region Type, 2016 and 2024
  • Figure 25: Tumor Ablation Market Attractiveness Analysis, By Region Type
  • Figure 26: North America Tumor Ablation Market Size (US$ Mn) Forecast, 2015-2024
  • Figure 27: North America Market Attractiveness Analysis by Country
  • Figure 28: North America Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
  • Figure 29: North America Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
  • Figure 30: North America Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
  • Figure 31: North America Market Value Share Analysis by Country, 2016 and 2024
  • Figure 32: North America Market Attractiveness Analysis, By Disease Indication
  • Figure 33: North America Market Attractiveness Analysis, By Technology
  • Figure 34: North America Market Attractiveness Analysis, By End User
  • Figure 35: Europe Tumor Ablation Market Size (US$ Mn) Forecast, 2015-2024
  • Figure 36: Europe Market Attractiveness Analysis by Country
  • Figure 37: Europe Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
  • Figure 38: Europe Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
  • Figure 39: Europe Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
  • Figure 40: Europe Market Value Share Analysis by Country, 2016 and 2024
  • Figure 41: Europe Market Attractiveness Analysis, By Disease Indication
  • Figure 42: Europe Market Attractiveness Analysis, By Technology
  • Figure 43: Europe Market Attractiveness Analysis, By End User
  • Figure 44: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, 2015-2024
  • Figure 45: Asia Pacific Market Attractiveness Analysis by Country
  • Figure 46: Asia Pacific Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
  • Figure 47: Asia Pacific Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
  • Figure 48: Asia Pacific Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
  • Figure 49: Asia Pacific Market Value Share Analysis by Country, 2016 and 2024
  • Figure 50: Asia Pacific Market Attractiveness Analysis, By Disease Indication
  • Figure 51: Asia Pacific Market Attractiveness Analysis, By Technology
  • Figure 52: Asia Pacific Market Attractiveness Analysis, By End User
  • Figure 53: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, 2015-2024
  • Figure 54: Latin America Market Attractiveness Analysis by Country
  • Figure 55: Latin America Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
  • Figure 56: Latin America Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
  • Figure 57: Latin America Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
  • Figure 58: Latin America Market Value Share Analysis by Country, 2016 and 2024
  • Figure 59: Latin America Market Attractiveness Analysis, By Disease Indication
  • Figure 60: Latin America Market Attractiveness Analysis, By Technology
  • Figure 61: Latin America Market Attractiveness Analysis, By End User
  • Figure 62: MEA Tumor Ablation Market Size (US$ Mn) Forecast, 2015-2024
  • Figure 63: MEA Market Attractiveness Analysis by Country
  • Figure 64: MEA Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
  • Figure 65: MEA Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
  • Figure 66: MEA Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
  • Figure 67: MEA Market Value Share Analysis by Country, 2016 and 2024
  • Figure 68: MEA Market Attractiveness Analysis, By Disease Indication
  • Figure 69: MEA Market Attractiveness Analysis, By Technology
  • Figure 70: MEA Market Attractiveness Analysis, By End User
  • Figure 71: Global Tumor Ablation Market Share Analysis by Company (2015)

List of Table

  • Table 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016-2024
  • Table 02: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016-2024
  • Table 03: Global Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016-2024
  • Table 04: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Region Type, 2015-2024
  • Table 05: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016-2024
  • Table 06: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016-2024
  • Table 07: North America Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016-2024
  • Table 08: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016-2024
  • Table 09: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016-2024
  • Table 10: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016-2024
  • Table 11: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016-2024
  • Table 12: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016-2024
  • Table 13: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016-2024
  • Table 14: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016-2024
  • Table 15: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016-2024
  • Table 16: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016-2024
  • Table 17: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016-2024
  • Table 18: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016-2024
  • Table 19: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016-2024
  • Table 20: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016-2024
  • Table 21: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016-2024
  • Table 22: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016-2024
  • Table 23: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016-2024
  • Table 24: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016-2024
Back to Top